Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.

Brief summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Currently patients with breast cancer are treated with one of several very similar combinations of drugs. Analysis of biomarkers in tumor tissue may help doctors predict how well patients with breast cancer will respond to treatment and help doctors choose the best drug regimen to treat each patient. PURPOSE: This randomized phase III trial is studying giving different regimens of chemotherapy and comparing how well they work in treating women with large operable or locally advanced or inflammatory breast cancer. This study is also looking at whether analyzing a specific biomarker (p53) in tumor tissue may help doctors predict how well patients will respond to treatment and help doctors choose the best drug to treat each patient.

Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.

Trial details

status
COMPLETED
phase
PHASE3
study type
INTERVENTIONAL
enrollment
1856
sponsor
European Organisation for Research and Treatment of Cancer - EORTC
conditions
Breast Cancer
interventions
BIOLOGICAL: filgrastim; DRUG: cyclophosphamide; DRUG: docetaxel; DRUG: epirubicin hydrochloride; DRUG: fluorouracil; GENETIC: microarray analysis; OTHER: immunohistochemistry staining method; OTHER: laboratory biomarker analysis; PROCEDURE: biopsy; PROCEDURE: conventional surgery
start date
2001-03-01
primary completion date
2006-11-01
has results
false
data source
ClinicalTrials.gov
data processed
2026-10-29T09:00:05
modifications
selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Record

Archive ID
nct:NCT00017095
Published
Jan 27, 2003
Updated
Oct 24, 2013
Venue
ClinicalTrials.gov
ClinicalTrials.gov
NCT00017095
Categories
Breast Cancer
License
ClinicalTrials.gov terms (attribution, processing date, modifications noted)
Provenance
clinicaltrials

Topics